New NIDDK-CR policy has been released (
NOT-DK-24-003
) to align with the final NIH Data Management and Sharing (DMS) policy and NIDDK DMS guidance
Skip to Main Content
Search
NIDDK Central Repository
NIDDK Central Repository
Sign In / Register
Repository Resources
Studies
Material Counts
List of Approved Requestors
Publications
Helpful Information
General Information
For Requestors
For Submitters
Educational/Instructional Information
External Links
Requests
Data Request
Biospecimen Request
About R4R
About NIDDK-CR R4R
R4R News
Frequently Asked Questions
Site Navigation Map
Definitions
Contact the Repository
Home
chevron_right
Studies
chevron_right
Ancillary Studies
chevron_right
Genetic Analysis of Subjects Enrolled in the FSGS - Controlled Trial
Genetic Analysis of Subjects Enrolled in the FSGS - Controlled Trial
Main study
Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial
Contact name
Jeffrey Kopp
Contact phone
301-594-3403
Contact email
jeffreyk@intra.niddk.nih.gov
PI name
Jeffrey Kopp